Literature DB >> 11832625

ICH Harmonised Tripartite Guideline: Guideline for Good Clinical Practice.

.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11832625

Source DB:  PubMed          Journal:  J Postgrad Med        ISSN： 0022-3859            Impact factor:   1.476


× No keyword cloud information.
  50 in total

1.  Interviewer variability - quality aspects in a case-control study.

Authors:  Kerstin J Blomgren; Anders Sundström; Gunnar Steineck; Bengt-Erik Wiholm
Journal:  Eur J Epidemiol       Date:  2006       Impact factor: 8.082

Review 2.  A general description for Chinese medicine in treating premature ovarian failure.

Authors:  Jing Lin; Xue-Lian Li; Hui Song; Qian Li; Ming-Yan Wang; Xue-Min Qiu; Da-Jin Li; Ling Wang
Journal:  Chin J Integr Med       Date:  2017-03-07       Impact factor: 1.978

3.  Abatacept retention and clinical outcomes in rheumatoid arthritis: real-world data from the German cohort of the ACTION study and a comparison with other participating countries.

Authors:  Rieke Alten; Eugen Feist; Hanns-Martin Lorenz; Hubert Nüßlein; Reinhard E Voll; Melanie Chartier; Yedid Elbez; Christiane Rauch
Journal:  Clin Rheumatol       Date:  2019-07-12       Impact factor: 2.980

4.  Monocyte activation by interferon α is associated with failure to achieve a sustained virologic response after treatment for hepatitis C virus infection.

Authors:  Dennis J Hartigan-O'Connor; Din Lin; James C Ryan; Valentina A Shvachko; Myrna L Cozen; Mark R Segal; Norah A Terrault; Lewis L Lanier; M Michele Manos; Joseph M McCune
Journal:  J Infect Dis       Date:  2013-12-10       Impact factor: 5.226

5.  Epidermal growth factor receptor expression analysis in chemotherapy-naive patients with advanced non-small-cell lung cancer treated with gefitinib or placebo in combination with platinum-based chemotherapy.

Authors:  Giuseppe Giaccone; Renee B Iacona; Abderrahim Fandi; Mette Janas; Judith S Ochs; Roy S Herbst; David H Johnson
Journal:  J Cancer Res Clin Oncol       Date:  2008-09-12       Impact factor: 4.553

6.  Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.

Authors:  Steven P Marso; Darren K McGuire; Bernard Zinman; Neil R Poulter; Scott S Emerson; Thomas R Pieber; Richard E Pratley; Poul-Martin Haahr; Martin Lange; Kirstine Brown-Frandsen; Alan Moses; Simon Skibsted; Kajsa Kvist; John B Buse
Journal:  N Engl J Med       Date:  2017-06-12       Impact factor: 91.245

7.  Effect of tiger milk mushroom (Lignosus rhinocerus) supplementation on respiratory health, immunity and antioxidant status: an open-label prospective study.

Authors:  Eugenie Sin Sing Tan; Teik Kee Leo; Chung Keat Tan
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

8.  Clinical trials in a COVID-19 pandemic: Shared infrastructure for continuous learning in a rapidly changing landscape.

Authors:  Haley Hedlin; Ariadna Garcia; Yingjie Weng; Ziyuan He; Vandana Sundaram; Bryan Bunning; Vidhya Balasubramanian; Kristen Cunanan; Kristopher Kapphahn; Santosh Gummidipundi; Natasha Purington; Mary Boulos; Manisha Desai
Journal:  Clin Trials       Date:  2021-02-03       Impact factor: 2.486

9.  Impaired Myocardial Function Is Prognostic for Severe Respiratory Failure in the Course of COVID-19 Infection.

Authors:  Alvaro Petersen-Uribe; Alban Avdiu; Peter Martus; Katja Witzel; Philippa Jaeger; Monika Zdanyte; David Heinzmann; Elli Tavlaki; Verena Warm; Tobias Geisler; Karin Müller; Meinrad Gawaz; Dominik Rath
Journal:  Front Cardiovasc Med       Date:  2021-06-04

10.  Efficacy and safety of insulin degludec in a flexible dosing regimen vs insulin glargine in patients with type 1 diabetes (BEGIN: Flex T1): a 26-week randomized, treat-to-target trial with a 26-week extension.

Authors:  Chantal Mathieu; Priscilla Hollander; Bresta Miranda-Palma; John Cooper; Edward Franek; David Russell-Jones; Jens Larsen; Søren Can Tamer; Stephen C Bain
Journal:  J Clin Endocrinol Metab       Date:  2013-02-07       Impact factor: 5.958
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.